Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/15/16
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/07/14
End: 12/29/16
Due: 12/29/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| OCR002-SP103 - Oral Immediate Release Study | NCT03846843 | Ocera Therapeutics, Inc. | user2@example.com | None | 2016-08-15 | 2017-12-31 | 2018-12-31 | - | - | 2025-07-14 |
| Emergency Use of OCR-002 in Acute Liver Failure (ALF) | NCT01634230 | Ocera Therapeutics, Inc. | user2@example.com | None | - | - | - | - | - | 2025-07-14 |
| Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE) | NCT01966419 | Ocera Therapeutics, Inc. | user2@example.com | None | 2014-01-07 | 2016-12-29 | 2017-12-29 | - | - | 2025-07-14 |